Methotrexate and Blood immunoglobulin g decreased - a phase IV clinical study of FDA data
Blood immunoglobulin g decreased is found among people who take Methotrexate, especially for people who are female, 50-59 old, have been taking the drug for 1 - 2 years.
The phase IV clinical study analyzes which people take Methotrexate and have Blood immunoglobulin g decreased. It is created by eHealthMe based on reports of 517,446 people who have side effects when taking Methotrexate from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
517,446 people reported to have side effects when taking Methotrexate.
Among them, 116 people (0.02%) have Blood immunoglobulin g decreased.
What is Methotrexate?
Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 521,823 Methotrexate users for its effectiveness, alternative drugs and more.
What is Blood immunoglobulin g decreased?
Blood immunoglobulin g decreased is found to be associated with 658 drugs and 312 conditions by eHealthMe.
Number of Methotrexate and Blood immunoglobulin g decreased reports submitted per year:
Time on Methotrexate when people have Blood immunoglobulin g decreased *:
Gender of people who have Blood immunoglobulin g decreased when taking Methotrexate*:
Age of people who have Blood immunoglobulin g decreased when taking Methotrexate *:
Common drugs people take besides Methotrexate *:
Common side effects people have besides Blood immunoglobulin g decreased *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Methotrexate and have Blood immunoglobulin g decreased?Check whether Blood immunoglobulin g decreased is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Henien M, Carey B, Hullah E, Sproat C, Patel V, "methotrexate-associated osteonecrosis of the jaw: A report of two cases", Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2017 Dec .
How severe was Blood immunoglobulin g decreased and when was it recovered:
Expand to all the drugs that have ingredients of methotrexate sodium:
Alternative drugs to, pros and cons of Methotrexate:
- Methotrexate (521,823 reports)
Common Methotrexate side effects:
Browse all side effects of Methotrexate:a b c d e f g h i j k l m n o p q r s t u v w x y z
Blood immunoglobulin g decreased treatments and more:
- Blood immunoglobulin g decreased (2,235 reports)
COVID vaccines that are related to Blood immunoglobulin g decreased:
- Blood immunoglobulin g decreased in Moderna COVID Vaccine
- Blood immunoglobulin g decreased in Pfizer BioNTech Covid Vaccine
- Blood immunoglobulin g decreased in Johnson and Johnson Covid Vaccine
Common drugs associated with Blood immunoglobulin g decreased:
All the drugs that are associated with Blood immunoglobulin g decreased:
- Blood immunoglobulin g decreased (658 drugs)
Common conditions associated with Blood immunoglobulin g decreased:
All the conditions that are associated with Blood immunoglobulin g decreased:
- Blood immunoglobulin g decreased (312 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on methotrexate sodium (the active ingredients of Methotrexate) and Methotrexate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Obsessive-Compulsive Disorder in Dexmethylphenidate Hydrochloride, how severe and when it was recovered? - 4 seconds ago
- Vitamin B2 and Blindness - 5 seconds ago
- Skin Wrinkling and Eye Pain - 7 seconds ago
- Marinol and Posterior Reversible Encephalopathy Syndrome - 8 seconds ago
- Methotrexate and Blood Immunoglobulin G Decreased - 13 seconds ago
- Zyrtec and Elaprase drug interaction - 31 seconds ago
- Avapro and Nephritis Interstitial - 35 seconds ago
- Levaquin and Metastases To Spine - 38 seconds ago
- Profen and Wax Blockage - 41 seconds ago
- Creon and Cough - 43 seconds ago